Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Five batches of migraine injection recalled

  • Comment

The Medicines and Healthcare products Regulatory Agency has issued a drug alert over an injection used to relieve acute migraines called.

Five batches of the Imigran product – either treatment or refill packs – have been recalled by GlaxoSmithKline due to a manufacturing fault causing a small number of needles to protrude from the protective shield.

MHRA Defective Medicines Recall Centre manager Adam Burgess said: “The number of needles affected is thought to be very small and the risk to members of the public finding an affected syringe is extremely low.

“There is, however, a slight risk of infection from an unprotected needle and we would ask people to take extra care when using these syringes.”

The MHRA drug alert identified the affected batch numbers as:

  • Imigran Inj/ Subject Treatment – C640404, C638748, C636954
  • Imigran Inj / Subject Treatment Refill – C639899, C638737
  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.